Keyphrases
Amyotrophic Lateral Sclerosis
100%
Antisense Oligonucleotides
29%
Superoxide Dismutase 1 (SOD1)
27%
Neurodegenerative Diseases
14%
Central Nervous System
13%
TAR DNA-binding Protein 43 (TDP-43)
13%
C9orf72
12%
Motor Neuron
11%
Frontotemporal Dementia
11%
Cerebrospinal Fluid
9%
Clinical Trials
8%
Placebo
8%
Duchenne muscular Dystrophy
8%
Spinal Cord
7%
Motor Neuron Disease
7%
Tauopathy
7%
Becker muscular Dystrophy
6%
Alzheimer's Disease
6%
MicroRNA
6%
Reldesemtiv
6%
Antisense Oligonucleotide Therapy
5%
Mitochondria
5%
Mouse Model
5%
Muscular Dystrophy
5%
Neuroscience
Amyotrophic Lateral Sclerosis
67%
Antisense Oligonucleotide
22%
Neurodegenerative Disorder
15%
Copper Zinc Superoxide Dismutase
11%
Frontotemporal Dementia
11%
Central Nervous System
10%
MicroRNA
8%
Tauopathy
8%
Alzheimer's Disease
7%
SOD1
7%
Messenger RNA
5%
Motor Neuron Disease
5%
Astrocyte
5%
Muscle Disorder
5%
In Vivo
5%
Biochemistry, Genetics and Molecular Biology
Antisense
14%
Superoxide Dismutase
14%
Tau
12%
Liquid
12%
SOD1
11%
Oligonucleotide
11%
Motor Neuron
9%
RNA
7%
Transactive Response Dna Binding Protein-43
7%
Mitochondrion
6%
Clinical Trial
6%
Pharmacodynamics
6%